Caption Management, LLC Alkermes Plc. Call Options Transaction History

Caption Management, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $197,285 - $231,540	-8,500 Reduced 22.08%	30,000 $723,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $224,400 - $276,760	8,500 Added 28.33%	38,500 $1.04 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $815,100 - $959,100	30,000 New	30,000 $840,000
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $19 Million - $21.8 Million	750,000 New	750,000 $21.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $110,000 - $159,350	5,000 Added 20.0%	30,000 $669,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $924,000 - $1.07 Million	-35,000 Reduced 58.33%	25,000 $745,000
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $3.73 Million - $4.52 Million	-161,500 Reduced 72.91%	60,000 $1.58 Million
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $2.67 Million - $3.99 Million	124,300 Added 127.88%	221,500 $5.15 Million
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $9.58 Million - $13.2 Million	-410,000 Reduced 80.84%	97,200 $3 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $8.12 Million - $10.9 Million	432,200 Added 576.27%	507,200 $12.4 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $979,698 - $1.25 Million	53,800 Added 253.77%	75,000 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $326,268 - $468,520	21,200 New	21,200 $424,000
Q4 2018 Jan 30, 2019	SELL	$27.94 - $44.61 $977,900 - $1.56 Million	-35,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $1.35 Million - $1.61 Million	35,000 New	35,000 $1.49 Million

363

182M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.05B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.